Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis

被引:0
|
作者
Nakamura, T
Liu, J
Morii, H
Huang, Q
Zhu, H
Qu, Y
Hamaya, E
Thiebaud, D
机构
[1] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[2] Gen Hosp PLA, Beijing, Peoples R China
[3] Osaka City Univ, Osaka 558, Japan
[4] Shanghai Peoples Hosp 6, Shanghai, Peoples R China
[5] Shanghai Huadong Hosp, Shanghai, Peoples R China
[6] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S430 / S431
页数:2
相关论文
共 50 条
  • [11] Early effect of strontium ranelate on clinical,vertebral fractures in women with postmenopausal osteoporosis
    Meunier, PJ
    Marquis, P
    Lemmel, EM
    Martin, TJ
    Sawicki, A
    Isaia, G
    Benhamou, C
    Walravens, M
    Beck-Nielsen, H
    Diaz-Curiel, M
    Seeman, E
    Reginster, JY
    BONE, 2003, 32 (05) : S222 - S222
  • [12] Raloxifene for postmenopausal osteoporosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1022): : 29 - 30
  • [13] Raloxifene decreases the risk of new moderate or severe vertebral fractures in postmenopausal women with osteoporosis.
    Adachi, J
    Crans, GG
    Lu, Y
    Fuerst, T
    Wong, M
    Harper, KD
    Siris, E
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S255 - S255
  • [14] Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis
    Takuo Fujita
    Yoshio Fujii
    Hiromi Munezane
    Mutsumi Ohue
    Yasuyuki Takagi
    Journal of Bone and Mineral Metabolism, 2010, 28 : 477 - 484
  • [15] The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis
    Solling, Anne Sophie Koldkjaer
    Harslof, Torben
    Langdahl, Bente
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (5-6) : 105 - 115
  • [16] Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis
    Kendler, D. L.
    Palacios, S.
    Cox, D. A.
    Stock, J.
    Alam, J.
    Dowsett, S. A.
    Zanchetta, J.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) : 1091 - 1101
  • [17] Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis
    D. L. Kendler
    S. Palacios
    D. A. Cox
    J. Stock
    J. Alam
    S. A. Dowsett
    J. Zanchetta
    Osteoporosis International, 2012, 23 : 1091 - 1101
  • [18] Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis
    Fujita, Takuo
    Fujii, Yoshio
    Munezane, Hiromi
    Ohue, Mutsumi
    Takagi, Yasuyuki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (04) : 477 - 484
  • [19] Clinical efficacy of raloxifene in postmenopausal women
    Agnusdei, D
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 85 (01): : 43 - 46
  • [20] Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women
    Olevsky, Olga M.
    Martino, Silvana
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (04): : 790 - 796